View All Documents & Correspondence
A Composition Comprising Docosahexaenoic Acid, And Caralluma Fimbriata Extract And Uses Thereof
Abstract: The present disclosure relates to a composition comprising docosahexaenoic acid, and Caralluma fimbriata extract which at particular weight ratios exhibits enhanced effect in inhibiting fat accumulation. Also provided are methods and use of said composition.
Notices, Deadlines & Correspondence
Patent Information
Applicants
ITC LIMITED
Inventors
1. DEVAN, Sabarinathan
2. RADHAKRISHNAN, Yashwanth
3. Nandakumar K S
4. CHITTUR, Lakshmanan Chandrasekharan
Specification
Claims:1. A composition comprising:
a. docosahexaenoic acid; and
b. Caralluma fimbriata extract,
wherein docosahexaenoic acid to Caralluma fimbriata extract w/w ratio in said composition is in the range of 1:5 to 5:1.
2. The composition as claimed in claim 1, wherein docosahexaenoic acid concentration in said composition is in the range of 0.00083% to 0.00417%, and Caralluma fimbriata extract concentration in said composition is in the range of 0.00083% to 0.00417%.
3. The composition as claimed in claim 1, wherein docosahexaenoic acid to Caralluma fimbriata extract w/w ratio in said composition is in the range of 1:4 - 4:1.
4. The composition as claimed in claim 3, wherein docosahexaenoic acid concentration in said composition is in the range of 0.001% to 0.004%, and Caralluma fimbriata extract concentration in said composition is in the range of 0.001% to 0.004%.
5. The composition as claimed in claim 1 or claim 3, wherein docosahexaenoic acid to Caralluma fimbriata extract w/w ratio in said composition is 1:4.
6. The composition as claimed in claim 5, wherein docosahexaenoic acid concentration in said composition is 0.001%, and Caralluma fimbriata extract concentration in said composition is 0.004%.
7. The composition as claimed in claim 1 or claim 3, wherein docosahexaenoic acid to Caralluma fimbriata extract w/w ratio in said composition is 3:2.
8. The composition as claimed in claim 7, wherein docosahexaenoic acid concentration in said composition is 0.003%, and Caralluma fimbriata extract concentration in said composition is 0.002 %.
9. The composition as claimed in claim 1 or claim 3, wherein docosahexaenoic acid to Caralluma fimbriata extract w/w ratio in said composition is 1:1.
10. The composition as claimed in claim 9, wherein docosahexaenoic acid concentration in said composition is 0.0025%, and Caralluma fimbriata extract concentration in said composition is 0.0025%.
11. The composition as claimed in claim 1 or claim 3, wherein docosahexaenoic acid to Caralluma fimbriata extract w/w ratio in said composition is 2:3.
12. The composition as claimed in claim 11, wherein docosahexaenoic acid concentration in said composition is 0.002%, and Caralluma fimbriata extract concentration in said composition is 0.003%.
13. The composition as claimed in claim 1 or claim 3, wherein docosahexaenoic acid to Caralluma fimbriata extract w/w ratio in said composition is 4:1.
14. The composition as claimed in claim 13, wherein docosahexaenoic acid concentration in said composition is 0.004 %, and Caralluma fimbriata extract concentration in said composition is 0.001%.
15. The composition as claimed in any of the claims 1-14, further comprising suitable carriers, diluents, and excipients.
16. A method of preparing a composition as claimed in any of the claims 1-15.
17. A method for inhibiting fat accumulation, said method comprising:
a. obtaining a composition as claimed in any of the claims 1-15; and
b. contacting said composition with fat cells,
wherein said method is for inhibiting fat accumulation.
, Description:As Attached
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 201641010903-NBA INTIMATION TO APPLICANT COMPLY WITH REQUIREMENT-23-09-2024.pdf | 2024-09-23 |
| 1 | Form 5 [29-03-2016(online)].pdf | 2016-03-29 |
| 2 | 201641010903-Written submissions and relevant documents [22-12-2023(online)].pdf | 2023-12-22 |
| 2 | Form 3 [29-03-2016(online)].pdf | 2016-03-29 |
| 3 | Drawing [29-03-2016(online)].pdf | 2016-03-29 |
| 3 | 201641010903-FORM-26 [12-12-2023(online)].pdf | 2023-12-12 |
| 4 | Description(Complete) [29-03-2016(online)].pdf | 2016-03-29 |
| 4 | 201641010903-FORM-26 [07-12-2023(online)].pdf | 2023-12-07 |
| 5 | Other Patent Document [26-05-2016(online)].pdf | 2016-05-26 |
| 5 | 201641010903-Correspondence to notify the Controller [06-12-2023(online)].pdf | 2023-12-06 |
| 6 | Form 26 [26-05-2016(online)].pdf | 2016-05-26 |
| 6 | 201641010903-US(14)-HearingNotice-(HearingDate-08-12-2023).pdf | 2023-11-09 |
| 7 | 201641010903-Power of Attorney-300516.pdf | 2016-07-22 |
| 7 | 201641010903-FER_SER_REPLY [09-02-2023(online)].pdf | 2023-02-09 |
| 8 | 201641010903-Form 1-300516.pdf | 2016-07-22 |
| 8 | 201641010903-FER.pdf | 2022-08-11 |
| 9 | 201641010903-Correspondence-F1-PA-300516.pdf | 2016-07-22 |
| 9 | 201641010903-FORM 18 [27-03-2020(online)].pdf | 2020-03-27 |
| 10 | 201641010903-Correspondence-F1-PA-300516.pdf | 2016-07-22 |
| 10 | 201641010903-FORM 18 [27-03-2020(online)].pdf | 2020-03-27 |
| 11 | 201641010903-FER.pdf | 2022-08-11 |
| 11 | 201641010903-Form 1-300516.pdf | 2016-07-22 |
| 12 | 201641010903-FER_SER_REPLY [09-02-2023(online)].pdf | 2023-02-09 |
| 12 | 201641010903-Power of Attorney-300516.pdf | 2016-07-22 |
| 13 | 201641010903-US(14)-HearingNotice-(HearingDate-08-12-2023).pdf | 2023-11-09 |
| 13 | Form 26 [26-05-2016(online)].pdf | 2016-05-26 |
| 14 | 201641010903-Correspondence to notify the Controller [06-12-2023(online)].pdf | 2023-12-06 |
| 14 | Other Patent Document [26-05-2016(online)].pdf | 2016-05-26 |
| 15 | 201641010903-FORM-26 [07-12-2023(online)].pdf | 2023-12-07 |
| 15 | Description(Complete) [29-03-2016(online)].pdf | 2016-03-29 |
| 16 | 201641010903-FORM-26 [12-12-2023(online)].pdf | 2023-12-12 |
| 16 | Drawing [29-03-2016(online)].pdf | 2016-03-29 |
| 17 | 201641010903-Written submissions and relevant documents [22-12-2023(online)].pdf | 2023-12-22 |
| 17 | Form 3 [29-03-2016(online)].pdf | 2016-03-29 |
| 18 | Form 5 [29-03-2016(online)].pdf | 2016-03-29 |
| 18 | 201641010903-NBA INTIMATION TO APPLICANT COMPLY WITH REQUIREMENT-23-09-2024.pdf | 2024-09-23 |
Search Strategy
| 1 | SearchHistory-patseerE_10-08-2022.pdf |